Embecta (EMBC) Interest & Investment Income (2022 - 2026)
Embecta's (EMBC) quarterly Interest & Investment Income came in at -$22.6 million in Q1 2026, up 15.36% year-on-year from -$19.6 million in Q1 2025, and up 6.22% quarter-over-quarter from -$24.1 million in Q4 2025.
Embecta (EMBC) Interest & Investment Income (2022 - 2026) Analysis & Trends
Embecta has disclosed Interest & Investment Income across 5 years of filings, most recently posting -$22.6 million for Q1 2026.
- Interest & Investment Income for Q1 2026 came in at -$22.6 million, up 15.36% year-over-year; the trailing twelve-month figure through Mar 2026 was -$99.4 million (up 10.77% YoY), and the FY2025 annual result was -$107.3 million, up 4.45% from the prior year.
- Interest & Investment Income came in at -$22.6 million for Q1 2026 at Embecta, up from -$24.1 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of -$4.9 million in Q1 2022 to a low of -$29.0 million in Q3 2024.
- The 5-year median for Interest & Investment Income is -$26.7 million (2025), against an average of -$24.7 million.
- Across the five-year window, Interest & Investment Income plunged 446.94% in 2023 and gained 15.36% in 2026, its largest moves.
- Embecta's Interest & Investment Income stood at -$25.6 million in 2022, then decreased by 8.2% to -$27.7 million in 2023, then dropped by 0.72% to -$27.9 million in 2024, then increased by 13.62% to -$24.1 million in 2025, then rose by 6.22% to -$22.6 million in 2026.
- The last three Interest & Investment Income figures came in at -$22.6 million (Q1 2026), -$24.1 million (Q4 2025), and -$26.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 9.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -136.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 12.29 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 5.10 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -62.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.91 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -66.00 Mn |
| 10 | Embecta | 183.23 Mn | -10.17 Mn | 127.80 Mn | -22.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.60 Mn |
| Dec 31, 2025 | -24.10 Mn |
| Sep 30, 2025 | -26.10 Mn |
| Jun 30, 2025 | -26.60 Mn |
| Mar 31, 2025 | -26.70 Mn |
| Dec 31, 2024 | -27.90 Mn |
| Sep 30, 2024 | -29.00 Mn |
| Jun 30, 2024 | -27.80 Mn |
| Mar 31, 2024 | -27.80 Mn |
| Dec 31, 2023 | -27.70 Mn |
| Sep 30, 2023 | -27.60 Mn |
| Jun 30, 2023 | -27.00 Mn |
| Mar 31, 2023 | -26.80 Mn |
| Dec 31, 2022 | -25.60 Mn |
| Sep 30, 2022 | -21.80 Mn |
| Jun 30, 2022 | -19.50 Mn |
| Mar 31, 2022 | -4.90 Mn |